Detalhe da pesquisa
1.
Anlotinib Combined With Toripalimab as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Prospective, Multicenter, Phase II Study.
Oncologist
; 28(12): e1239-e1247, 2023 Dec 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37329569
2.
Lichenoid drug eruption caused by imatinib mesylate in a Chinese patient with gastrointestinal stromal tumor.
Int J Clin Pharmacol Ther
; 54(9): 719-22, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27345285